| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698365 | Clinical Oncology | 2014 | 7 Pages |
Abstract
This large series confirms, in a standard practice setting, similar efficacy and tolerability of treatment as previously reported in our phase I-II study. The benefit to patients with a gross tumour volume >48Â cm3 may be limited.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Youl, S. Hashem, A. Brade, B. Cummings, L.A. Dawson, S. Gallinger, D. Hedley, H. Jiang, J. Kim, M.K. Krzyzanowska, J. Ringash, R. Wong, J. Brierley,